JINLING PHARM.: In the first quarter, the net profit attributable to the parent company was 22.982 million yuan, a year-on-year decline of 49.07%
On April 27th, JINLING PHARM. announced that in the first quarter of 2025, it achieved operating revenue of 810 million yuan, a year-on-year decrease of 4.25%; the net profit attributable to shareholders of the listed company was 22.982 million yuan, a year-on-year decline of 49.07%; the basic earnings per share were 0.0370 yuan